Skip to main content

DocGo Inc. (DCGO)

Stock NASDAQ

$0.18

+0.00 (+1.98%)

Delayed quote.

Price history

Daily close
DCGO daily closing price, Nov 24, 2025 to Nov 20, 2026 Closed at $1.02 on Nov 24, 2025 and $0.18 on Nov 20, 2026, a change of -82.84%. Range $0.17 to $1.08.
Daily closes, Nov 24, 2025 to Nov 20, 2026 (250 trading days).
Start
$1.02
Latest close
$0.18
Period change
-82.84%
Period low
$0.17
Period high
$1.08

Key metrics

Market cap
$17.32M
Volume
1.02M
Average volume
737.1K
52-week range
$0.17 – $1.10
Beta
1.00
Last dividend
—
EPS (TTM)
-$1.85
P/E ratio
-0.48
Revenue (TTM)
$297.34M
Net income (TTM)
-$181.25M
Total assets
$173.90M
Total debt
$24.64M
Cash and equivalents
$19.11M

Key financials (trailing twelve months).

Company profile

DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NASDAQ
CEO
Lee Bienstock
Employees
3,568
Headquarters
New York City, NY, US
IPO date
2020-12-17

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Revenue$322.20M$616.56M$624.29M
Gross profit$98.76M$213.57M$195.38M
Operating income-$89.16M$28.69M$15.05M
EBITDA-$170.82M$45.56M$32.73M
Net income-$182.40M$19.99M$6.86M
Diluted EPS-$1.84$0.18$0.06
Balance sheet
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Cash and equivalents$51.02M$89.24M$59.29M
Total assets$217.10M$455.62M$490.45M
Total liabilities$91.23M$140.44M$185.28M
Total debt$29.18M$57.19M$46.50M
Shareholders’ equity$144.01M$320.92M$300.79M
Cash flow statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Operating cash flow$34.45M$70.34M-$64.22M
Capital expenditure-$7.43M-$5.84M-$10.13M
Free cash flow$27.02M$64.50M-$74.35M

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Revenue$73.43M$73.42M$75.55M$74.94M$70.81M$80.42M
Gross profit$24.46M$22.41M$23.88M$24.36M$18.13M$25.42M
Operating income-$17.28M-$17.92M-$18.71M-$32.44M-$41.98M-$17.48M
EBITDA$2.64T-$15.15M-$13.93M-$107.74M-$21.27M-$13.49M
Net income-$16.60M-$15.82M-$14.76M-$134.07M-$27.77M-$11.16M
Diluted EPS-$0.17-$0.16-$0.15-$1.37-$0.28-$0.11
Balance sheet
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Cash and equivalents$19.11M$25.23M$35.68M$51.02M$73.36M$104.16M
Total assets$173.90M$186.82M$209.23M$217.10M$353.78M$408.26M
Total liabilities$94.92M$91.04M$98.02M$91.23M$93.12M$120.53M
Total debt$24.64M$25.91M$28.51M$29.18M$29.46M$60.45M
Shareholders’ equity$105.08M$119.05M$132.31M$144.01M$270.53M$297.28M
Cash flow statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Operating cash flow-$3.62M-$9.24M-$4.66M-$10.47M$1.66M$34.04M
Capital expenditure-$120.8K-$320.8K-$430.3K-$2.13M-$1.56M-$2.01M
Free cash flow-$3.74M-$9.56M-$5.09M-$12.60M$101.2K$32.04M